COVID-19 Situation Report 375 - Academic, educational, research, and ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
For citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Feb 8
COVID-19
Situation Report 375
Centre for Infectious Disease Epidemiology and Research (CIDER)
For citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
i. Background
In December, China notified the World Health Organization (WHO) of several cases of human respiratory
illness, which appeared to be linked to an open seafood and livestock market in the city of Wuhan. The
infecting agent has since been identified as a novel coronavirus, previously known as 2019-nCoV and now
called SAR-CoV-2; The new name of the disease has also been termed COVID-19, as of 11th February 2020.
Although the virus is presumed zoonotic in origin, person-to-person spread is evident. Screening of
travellers, travel bans and quarantine measures are being implemented in many countries. Despite these
precautions, it is anticipated that more cases will be seen both inside China and internationally. The WHO
declared the outbreak of COVID-19 constitutes a Public Health Emergency of International Concern on 30
January. On 11 March, 2020, WHO declared the coronavirus outbreak a pandemic as the global death toll
rose above 4,600 and the number of confirmed cases topped 125,000. This report aims to update Global
Risk Assessment, Global Epidemiology, Quarantine Orders, Travel Ban/Advisory by countries, WHO’s and
CDC’s Guidance and Protocols and Scientific publication on a daily basis. New updates in the tables are
bolded.
1|Page Centre for infectious disease epidemiology and research
For citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
ii. Global Risk Assessment
Table 1. Risk assessment of COVID-19 by WHO regions (Updated as of 8 Feb 2021, 1500H SGT)
Transmissibilit Severity of Availability of Treatment/ Overall
Environmental Risk
y Disease Vaccination# Risk
Global (n=197 countries)
High Moderate High Limited
Globally, 188 (95.4%) countries (excluding Based on CDC Case The number of countries that have
territories*) have reported the outbreak. data, median fatality rate commenced mass vaccination in each
R0 is estimated is currently region are as follows: Combined WPRO
Using an incidence >20 cases/100,000 to be 5.8 (95% at 2.18% and SEARO (9 countries), EURO (37
people over the past 14-days as cut-off for CI 4.4–7.7), globally. countries), EMRO (7 countries),
a surge in cases, the number of countries but the Most cases Americas (10 countries), and Africa (2
reporting a surge in cases in each region estimated present as countries).&
are as follows: Combined WPRO and effective flu-like
SEARO (6 countries), reproduction illness. International clinical trials published on
EURO (48 countries), number in 171 2 September confirm that cheap, widely
EMRO (13 countries), Americas (29 countries available steroid drugs can help
countries), and Africa (16 countries). ranged from seriously ill patients survive Covid-19.
0.021 to 2.9.$ The World Health Organization issued
Only 4 (2%) countries/territories have no new treatment guidance, strongly
reported restrictions on inbound arrivals, recommending steroids to treat
while 144 (78%) countries/territories have severely and critically ill patients, but
High
partially reopened their borders – require not to those with mild disease. [4]
arrivals to produce a negative COVID-19
test result and/or undergo self-quarantine Researchers have found all regimens of
upon arrival. 53 (29%) anticoagulants to be far superior to no
countries/territories are totally closed to anticoagulants in COVID-19 patients.
international arrivals. [1] More specifically, patients on both a
“therapeutic” or full dose and those on
On October 7, the Centers for Disease a “prophylactic” or lower dose, showed
Control and Prevention (CDC) confirmed about a 50% higher chance of survival
airborne transmission of SARS-CoV-2. [2] and roughly a 30% lower chance of
intubation, than those not on
The U.S. CDC has revised its guidance on anticoagulants. It was observed that
COVID-19 quarantine period from 14 days therapeutic and prophylactic
to 7-10 days, based one's test results and subcutaneous low-molecular weight
symptoms. Individuals without symptoms heparin and therapeutic oral apixaban
only need quarantine for 10 days without may lead to better results. [3]
testing; those tested negative can
quarantine for 7 days. [14]
Western Pacific Region and South-East Asia Region (n=41 countries)
Moderate Moderate Moderate High
33 (80.5%) countries have reported As of February Case Vaccine coverage information was
outbreaks; but only 6 (14.6%) are 3, the fatality rate available for 4 countries as of 6
reporting a surge in cases. estimated is 1.56%. February 2021. Coverage for: i) at least
1 dose was at
For citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Highest incidence over the past 14 days ranged from
were reported from Indonesia, Japan, 0.15-2.9.$
Malaysia, Maldives and Sri Lanka and
highest case numbers were reported from
India, Indonesia, Japan, Malaysia and
Philippines.
At least 20 countries have closed their
borders, 22 countries have opened their
borders partially conditionally, and none
are allowing free travel.
European Region (n=53 countries)
High Moderate High High
52 (98.1%) countries have reported with As of February Case Vaccine coverage information was
outbreaks; 48 (90.6%) countries are 3, the fatality rate available for 31 countries as of 6
reporting a surge in cases. estimated is 2.20%. February 2021. Coverage for i) at least 1
effective dose was atFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Region of the Americas (n=35 countries)
High Moderate High High
35 (100%) countries have reported with As of February Case Vaccine coverage information was
outbreak; 29 (82.9%) countries are 3, the fatality rate available for 8 countries as of 6
reporting a surge in cases. estimated is 2.32%. February 2021. Coverage for: i) at least
effective 1 dose was atFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
ranged from Ethiopia has approved the use of
Highest incidence over the past 14 days 0.021-2.1.$ Dexamethasone treatment for seriously
were reported from Botswana, Cabo ill COVID-19 patients. [13]
Verde, Nambia, Seychelles and South
Africa and highest case numbers were
reported from Ghana, Mozambique,
Nigeria, South Africa and Zambia.
At least 9 countries have closed their
borders, 38 countries have opened their
borders partially conditionally, and no
country is allowing free travel.
*Only WHO member states are included. 30 territories that have reported cases (with the exception of Palestine)
are excluded from the tabulation of total countries affected/imported/local cases and case fatality rate. Refer to
WHO situation reports or table 4 for information.
#
Ongoing clinical trials of vaccines and treatment are summarised in section X
%
This is by no means an exhaustive list of lockdowns imposed globally. Tally is subjected to publication bias
whereby certain countries may receive less media attention and hence, coverage on their travel bans
implemented.
$
https://epiforecasts.io/covid/posts/global/
^
Differences between R0 and effective R can be found here https://www.coronavirustoday.com/r-number-refers-
either-basic-or-effective-reproduction-number
&
https://ourworldindata.org/covid-vaccinations; High vaccine coverage defined as >70% population with full
vaccination
€
https://covid19.trackvaccines.org/vaccines/
5|Page Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
iii. Global Epidemiology
Table 2. Summary of COVID-19 cases & fatalities globally (Updated as of 8 Feb 2021, 1500H SGT)
Case-
No. of Total Cases Case-
Fatality
Countries/ Total Global Outside Total Fatality
Rate (%) R0
Territories Cases Mainland Deaths Rate (%)
[outside
with Cases China [overall]
China]
5.8 (95% CI 4.4–
219 106,712,241 106,622,535 2,327,942 2.18% 2.18%
7.7)^
^Based on early release as of 10th April, 2020: https://wwwnc.cdc.gov/eid/article/26/7/20-0282_article
Table 3. Comparison with other viruses
Virus Incubation Period (Days) Case Fatality Rate (%) R0
Median = 5.1$
SARS-CoV-2 2.18 5.8 (95% CI 4.4–7.7) ^
(2-14) or up to 24*
SARS-CoV 2-7 9.6 2.0For citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Figure 2. Growth Factor excluding mainland China
Figure 3. Growth Factor of Novel Coronavirus Daily Deaths (Mainland China + Other Countries)
Growth Factor = every day’s cases/cases on previous day. A growth factor above 1 indicates an increase, whereas one between 0 and 1 is a sign
of decline, with the quantity eventually becoming zero. A growth factor below 1 (or above 1 but trending downward) is a positive sign, whereas
a growth factor constantly above 1 is the sign of exponential growth.
Source: https://www.worldometers.info/coronavirus/coronavirus-cases/
7|Page Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Case Breakdown by Countries
Live update of COVID-19 global cases can be found at
https://storymaps.arcgis.com/stories/a1746ada9bff48c09ef76e5a788b5910
Table 4. Breakdown of COVID-19 confirmed cases and deaths (Updated as of 8 Feb 2021, 1500 SGT)
Total
Country Total Cases Change Change Total Recovered Region
Deaths
1 USA 27,611,403 +91767 474,933 +1405 17,354,388 Americas
2 India 10,838,843 +11673 155,114 +86 10,533,076 SEARO
3 Brazil 9,524,640 +26845 231,561 +492 8,397,187 Americas
4 Russia 3,983,197 +31964 77,068 +839 3,472,091 EURO
5 UK 3,945,680 +15845 112,465 +373 1,915,629 EURO
6 France 3,337,048 +19715 78,965 +171 232,977 EURO
7 Spain 2,971,914 0 61,386 0 N/A EURO
8 Italy 2,636,738 +11640 91,273 +270 2,118,441 EURO
9 Turkey 2,531,456 +6670 26,797 +112 2,420,706 EURO
10 Germany 2,291,441 +6442 62,128 +130 2,041,300 EURO
11 Colombia 2,157,216 +6009 55,993 +300 2,027,333 Americas
12 Argentina 1,980,347 +3658 49,171 +61 1,778,965 Americas
13 Mexico 1,932,145 +6065 166,200 +414 1,490,077 Americas
14 Poland 1,550,255 +4725 39,087 +93 1,307,161 EURO
15 South Africa 1,476,135 +2435 46,290 +110 1,360,204 Africa
16 Iran 1,466,435 +7065 58,469 +57 1,253,554 EMRO
17 Ukraine 1,246,990 +5511 23,644 +128 1,075,743 EURO
18 Peru 1,186,698 +6220 42,308 +187 1,094,573 Americas
19 Indonesia 1,157,837 +10827 31,556 +163 949,990 SEARO
20 Czechia 1,037,405 +7293 17,333 +204 922,223 EURO
21 Netherlands 1,005,760 +3934 14,403 +48 N/A EURO
22 Canada 804,260 +3203 20,767 +65 738,766 Americas
23 Portugal 765,414 +3508 14,158 +204 606,166 EURO
24 Chile 751,886 +3804 18,974 +79 710,029 Americas
25 Romania 745,318 +1975 18,881 +72 691,377 EURO
26 Belgium 725,610 +4178 21,389 +94 49,911 EURO
27 Israel 692,101 +6518 5,121 +50 619,329 EURO
28 Iraq 628,550 +1134 13,120 +9 600,193 EMRO
29 Sweden 588,062 0 12,115 0 N/A EURO
30 Pakistan 555,511 +2383 12,026 +112 511,502 EMRO
31 Bangladesh 538,062 +292 8,205 +15 483,372 SEARO
32 Philippines 537,310 +1789 11,179 +69 499,798 WPRO
33 Switzerland 531,873 0 9,613 +7 317,600 EURO
34 Morocco 475,355 +389 8,394 +13 454,504 EMRO
35 Austria 423,839 +1317 8,012 +18 402,053 EURO
36 Serbia 407,881 +1529 4,126 +14 31,536 EURO
37 Japan 403,435 +2080 6,338 +95 362,231 WPRO
8|Page Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
38 Hungary 376,495 +1370 13,090 +64 279,763 EURO
39 Saudi Arabia 370,278 +317 6,402 +5 361,515 EMRO
40 Jordan 335,154 +1299 4,379 +10 320,335 EMRO
41 Panama 327,091 +627 5,480 +25 292,302 Americas
42 UAE 326,495 +3093 921 +7 305,759 EMRO
43 Lebanon 319,917 +2081 3,616 +54 206,523 EMRO
44 Nepal 271,925 +119 2,038 +3 268,072 SEARO
45 Slovakia 263,326 +1552 5,199 +64 241,686 EURO
46 Georgia 262,228 +608 3,298 +29 254,350 EURO
47 Belarus 258,691 +1732 1,783 +10 247,177 EURO
48 Ecuador 258,282 +1167 15,012 +8 220,398 Americas
49 Malaysia 242,452 +3731 872 +15 190,339 WPRO
50 Croatia 235,402 +276 5,169 +25 227,485 EURO
51 Azerbaijan 231,154 +132 3,158 +2 225,246 EURO
52 Bolivia 227,967 +839 10,796 +43 168,040 Americas
53 Bulgaria 223,734 +182 9,331 +20 193,251 EURO
54 Dominican Republic 223,398 +1250 2,831 +30 167,214 Americas
55 Tunisia 217,086 +910 7,214 +52 173,862 EMRO
56 Ireland 203,568 +1020 3,686 +12 23,364 EURO
57 Denmark 201,621 +435 2,216 +1 192,695 EURO
58 Costa Rica 196,438 0 2,672 0 156,181 Americas
59 Kazakhstan 196,115 +2149 2,540 0 176,744 EURO
60 Lithuania 186,770 +492 2,937 +10 138,108 EURO
61 Slovenia 173,702 +501 3,623 +11 154,321 EURO
62 Kuwait 170,998 +962 966 +2 161,538 EMRO
63 Egypt 169,640 +534 9,651 +47 132,375 EMRO
64 Armenia 168,177 +240 3,123 +9 159,876 EURO
65 Moldova 164,569 +326 3,543 +13 153,785 EURO
66 Greece 163,946 +733 5,972 +21 147,254 EURO
67 Guatemala 163,137 +200 5,884 +30 149,342 Americas
68 Palestine 162,601 +572 1,881 +11 152,579 EMRO
69 Honduras 154,568 +1315 3,721 +27 61,817 Americas
70 Qatar 154,098 +408 250 0 146,910 EMRO
71 Ethiopia 142,338 +885 2,148 +3 125,619 Africa
72 Myanmar 141,304 0 3,168 0 127,229 SEARO
73 Nigeria 139,748 +506 1,667 +20 113,525 Africa
74 Paraguay 138,118 +515 2,826 +19 114,258 Americas
75 Oman 135,674 +633 1,534 +2 127,698 EMRO
76 Venezuela 130,116 +473 1,233 +5 122,081 Americas
77 Libya 124,026 +1132 1,953 +17 104,539 EMRO
78 Bosnia and Herzegovina 123,434 0 4,775 0 97,128 EURO
79 Algeria 109,088 +459 2,914 +5 74,692 Africa
80 Bahrain 107,329 +616 380 +1 101,168 EMRO
81 Kenya 101,819 +129 1,779 +3 84,361 Africa
9|Page Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
82 North Macedonia 94,798 +199 2,924 +8 83,999 EURO
83 China 89,706 +14 4,636 0 83,952 WPRO
84 Albania 85,336 +1124 1,460 +14 51,444 EURO
85 Kyrgyzstan 85,113 +121 1,431 +8 81,714 EURO
86 S. Korea 81,185 +289 1,474 +3 71,218 WPRO
87 Uzbekistan 79,162 +117 621 0 77,564 EURO
88 Latvia 71,800 +480 1,339 +12 59,897 EURO
89 Ghana 70,768 +722 457 +8 63,959 Africa
90 Sri Lanka 69,348 +772 356 +5 63,401 SEARO
91 Montenegro 65,227 +488 838 +2 56,731 EURO
92 Norway 64,772 +119 582 0 57,004 EURO
93 Zambia 62,633 +1206 853 +14 54,835 Africa
94 Singapore 59,699 +24 29 0 59,433 WPRO
95 El Salvador 56,237 0 1,692 +19 50,431 Americas
96 Afghanistan 55,359 +24 2,413 +3 48,041 EMRO
97 Luxembourg 51,848 +159 593 +1 48,421 EURO
98 Estonia 47,928 +416 461 +5 37,785 EURO
99 Finland 47,616 +354 688 0 31,000 EURO
100 Uruguay 45,311 +499 490 +9 38,976 Americas
101 Mozambique 44,600 +488 460 +9 27,162 Africa
102 Uganda 39,848 +27 327 0 14,349 Africa
103 Namibia 34,973 +129 375 +4 33,454 Africa
104 Zimbabwe 34,552 +65 1,326 +10 28,551 Africa
105 Cuba 32,831 +820 238 +5 26,739 Americas
106 Cyprus 31,759 +115 212 +1 2,057 EURO
107 Cameroon 31,394 0 474 0 29,501 Africa
108 Ivory Coast 29,825 +258 162 0 27,981 Africa
109 Australia 28,857 +7 909 0 26,089 WPRO
110 Senegal 28,760 +271 682 +7 23,559 Africa
111 Sudan 27,631 +131 1,835 +4 21,986 EMRO
112 Malawi 27,195 +320 856 +19 11,596 Africa
113 DRC 23,599 +114 681 +2 15,113 Africa
114 Thailand 23,557 +423 79 0 17,410 SEARO
115 Botswana 23,503 0 163 0 19,574 Africa
116 Angola 20,086 +24 475 0 18,540 Africa
117 Madagascar 19,360 +295 285 +4 18,490 Africa
118 Malta 18,676 +100 282 +3 16,053 EURO
119 French Polynesia 18,185 0 133 0 4,842 Non
120 Jamaica 17,085 +244 358 +1 12,271 Americas
121 Mauritania 16,807 +15 426 +1 16,005 Africa
122 Maldives 16,783 +127 55 +1 14,604 SEARO
123 Rwanda 16,451 +114 220 +3 12,342 Africa
124 French Guiana 16,296 0 79 0 9,995 Non
125 Eswatini 16,204 +23 604 0 11,614 Non
10 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
126 Guinea 14,687 +22 84 0 14,345 Africa
127 Syria 14,477 +69 952 +5 8,134 EMRO
128 Cabo Verde 14,423 +43 135 0 13,723 Africa
129 Tajikistan 13,308 0 90 0 13,218 EURO
130 Belize 12,037 0 306 0 11,479 Americas
131 Haiti 11,806 0 246 0 9,156 Americas
132 Gabon 11,457 0 71 0 10,797 Africa
133 Burkina Faso 11,285 +58 134 0 10,129 Africa
134 Hong Kong 10,636 +27 186 0 9,887 WPRO
135 Réunion 10,507 0 47 0 9,769 Non
136 Andorra 10,251 +45 106 +1 9,533 EURO
137 Mayotte 9,546 0 63 0 2,964 Non
138 Lesotho 9,380 0 183 0 2,706 Africa
139 Guadeloupe 9,226 0 155 0 2,242 Non
140 Suriname 8,671 +21 161 +1 8,020 Americas
141 Bahamas 8,256 0 176 0 6,819 Americas
142 Mali 8,176 +16 338 0 6,066 Africa
143 Congo 8,060 0 122 0 5,846 Africa
144 Guyana 7,982 +43 180 0 6,966 Americas
145 Trinidad and Tobago 7,616 +4 135 0 7,266 Americas
146 Aruba 7,223 +21 62 0 6,834 Non
147 Martinique 6,484 0 45 0 98 Non
148 Nicaragua 6,299 0 170 0 4,225 Americas
149 Iceland 6,021 0 29 0 5,959 EURO
150 Djibouti 5,947 +6 63 0 5,852 EMRO
151 Equatorial Guinea 5,578 0 86 0 5,358 Africa
152 Togo 5,483 +47 80 +1 4,550 Africa
153 CAR 4,989 0 63 0 4,885 Africa
154 Somalia 4,862 +8 134 0 3,720 EMRO
155 Curaçao 4,613 +8 21 0 4,535 Non
156 Niger 4,612 +14 165 0 3,970 Africa
157 South Sudan 4,355 0 66 0 3,663 Africa
158 Gambia 4,237 0 134 0 3,886 Africa
159 Benin 4,193 0 55 0 3,563 Africa
160 Gibraltar 4,182 +5 83 +3 3,944 Non
161 Channel Islands 3,896 +11 83 0 3,405 Non
162 Sierra Leone 3,785 +13 79 0 2,466 Africa
163 Chad 3,497 +24 125 0 2,895 Africa
164 San Marino 3,127 0 69 0 2,795 EURO
165 Comoros 3,086 0 108 0 2,334 Africa
166 Guinea-Bissau 2,780 +8 46 0 2,427 Africa
167 Liechtenstein 2,523 +5 52 0 2,424 Non
168 Eritrea 2,326 0 7 0 1,719 Africa
169 New Zealand 2,320 0 25 0 2,229 WPRO
11 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
170 Yemen 2,127 0 615 0 1,428 EMRO
171 Mongolia 2,073 +50 2 0 1,493 WPRO
172 Vietnam 2,001 +16 35 0 1,472 WPRO
173 Liberia 1,956 0 84 0 1,770 Africa
174 Sint Maarten 1,928 0 27 0 1,780 Non
175 Saint Lucia 1,813 0 18 0 875 Americas
176 Burundi 1,723 +6 3 0 773 Africa
177 Barbados 1,709 +33 18 0 1,400 Americas
178 Turks and Caicos 1,695 +41 9 0 1,319 Non
179 Monaco 1,655 +8 19 0 1,380 EURO
180 Seychelles 1,513 +9 7 +1 1,158 Africa
181 Sao Tome and Principe 1,351 0 18 0 1,060 Africa
182 St. Vincent Grenadines 1,269 +67 4 +1 409 Americas
183 Saint Martin 1,234 0 12 0 1,050 Non
184 Taiwan 927 +3 9 0 844 WPRO
185 Papua New Guinea 895 +4 9 0 846 WPRO
186 Bhutan 861 0 1 0 854 SEARO
187 Diamond Princess 712 0 13 0 699 NA
188 Bermuda 692 0 12 0 670 Non
189 Faeroe Islands 656 +1 1 0 652 Non
190 Mauritius 584 0 10 0 540 Africa
191 Tanzania 509 0 21 0 183 Africa
192 Cambodia 474 0 0 0 454 WPRO
193 Isle of Man 434 0 25 0 405 Non
194 Cayman Islands 405 0 2 0 368 Non
195 Caribbean Netherlands 360 0 3 0 244 Non
196 St. Barth 360 0 1 0 247 Non
197 Antigua and Barbuda 299 +11 7 0 187 Americas
198 Brunei 181 0 3 0 173 WPRO
199 Grenada 148 0 1 0 146 Americas
200 Dominica 121 0 0 0 110 Americas
201 British Virgin Islands 114 0 1 0 95 Non
202 Timor-Leste 80 0 0 0 61 SEARO
203 Fiji 56 0 2 0 53 WPRO
204 New Caledonia 49 0 0 0 47 Non
205 Macao 48 0 0 0 46 WPRO
206 Falkland Islands 45 0 0 0 36 Non
207 Laos 45 0 0 0 41 WPRO
208 Saint Kitts and Nevis 40 0 0 0 36 Americas
209 Greenland 30 0 0 0 30 Non
210 Vatican City 27 0 0 0 15 Non
211 Saint Pierre Miquelon 24 0 0 0 16 Non
212 Montserrat 17 +2 1 0 13 Non
213 Anguilla 17 0 0 0 15 Non
12 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
214 Solomon Islands 17 0 0 0 10 WPRO
215 Western Sahara 10 0 1 0 8 Non
216 MS Zaandam 9 0 2 0 7 NA
217 Wallis and Futuna 5 0 0 0 4 Non
218 Marshall Islands 4 0 0 0 4 WPRO
219 Samoa 2 0 0 0 2 WPRO
220 Micronesia 1 0 0 0 1 WPRO
221 Vanuatu 1 0 0 0 1 WPRO
Total 106,712,241 +368928 2,327,942 +7492 78,328,502
Figure 4. Areas with reported confirmed cases of COVID-19 (25 January – 31 January 2021)
Source: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
13 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Table 5. COVID-19 cases and deaths reported by provinces in China (Updated as of 8 Feb 2021, 1500H
SGT)
Existing Change from Total Change from
Area Active previous day Diagnosed Deaths previous day Recovered
Cases (Active cases) Cases (Deaths)
Heilongjiang 350 -37 1,609 13 0 1,246
Jilin 234 -13 573 3 0 336
Hebei 192 0 1,316 7 0 1,117
Shanghai 125 -3 1,739 7 0 1,607
Beijing 49 -2 1,046 9 0 988
Guangdong 48 +4 2,144 8 0 2,088
Shaanxi 22 -1 542 3 0 517
Fujian 15 0 545 1 0 529
Tianjin 15 0 346 3 0 328
Jiangsu 14 0 701 0 0 687
Hunan 11 0 1,033 4 0 1,018
Zhejiang 10 0 1,316 1 0 1,305
Sichuan 10 0 873 3 0 860
Shanxi 10 -1 239 0 0 229
Liaoning 7 -2 402 2 0 393
Inner Mongolia 5 -2 366 1 0 360
Shandong 1 0 866 7 0 858
Guangxi 1 0 267 2 0 264
Yunnan 1 0 231 2 0 228
Hubei 0 0 68,150 4,512 0 63,638
Henan 0 -1 1,303 22 -1 1,281
Anhui 0 0 994 6 0 988
Xinjiang 0 0 980 3 0 977
Jiangxi 0 0 935 1 0 934
Chongqing 0 0 591 6 0 585
Gansu 0 0 187 2 0 185
Hainan 0 0 171 6 0 165
Guizhou 0 0 147 2 0 145
Ningxia 0 0 75 0 0 75
Qinghai 0 0 18 0 0 18
Tibet 0 0 1 0 0 1
Source: https://ncov.dxy.cn/ncovh5/view/pneumonia
14 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
iv. Travel Bans/Advisories & Quarantine Orders
[1] Austria- Borders control with all neighbouring countries will be tightened and non-essential
travel should be avoided.
[2] Greece- Travel restriction will be extended until 22 Feb. Travelers will continue to submit
passenger locator form and negative covid-19 test result taken within 72 hours before arrival
and undergo a 7-days quarantine. UK arrivals will be required to take PCR on the 7th day of the
quarantine. Non-EU residents except for 10 countries will be banned from entering the country.
Flights from Turkey will remain banned.
v. Lockdowns
[1] Cyprus- On 8 Feb, Cyprus will move to the second phase of the COVID-19 measures relaxation.
Elementary schools and third grade of high schools will reopen. All shops, shopping centers and
malls will also reopen. Museums and other archaeological sites will reopen with measures in
place. Churches and other religious site will reopen with a limit of 50 churchgoers. Home visits
will be allowed for four people. Some sports activities will resume and training of 5 athletes will
be allowed. All employees returning to work are required to have negative rapid test which will
be performed weekly. Theatres and cinemas will reopen but limited to 50 people.
[2] Greece- Non-essential travel restriction for domestic flights have been extended until 15 Feb.
Essential travel for health and business reason, family reunification and returning of permanent
resident will be allowed.
[3] Malaysia- Restrictions for Chinese New Year reunion dinner will be eased. Limit of 15 family
members from different household living within 10km from each other will be allowed to dine
together. Family members will not be allowed to travel across state or district boundaries.
Religious activities within house of worship will be allowed on 11, 12 and 19 Feb but limited to
30 people and with measures in place. Prayers will be limited to 30 min followed by 30 minute
of cleaning and sanitation before the next session.
[4] UAE- From 7 Feb, Abu Dhabi will ban parties and gathering and close cinema. Marriage
ceremonies and family gathering will be limited to 10 people while funerals and mourning
services will allow 20 people. Capacity limit of 40% for malls, 50% for gyms, private beaches and
swimming pools. 60% for restaurants, coffee shops, hotels, public beaches and parks, 45% for
taxi and 75% for buses will be imposed.
vi. Military Surveillance
COVID-19 in British Troops in Kenya [1]
The British Army has reported four new cases in the British troop who are in Nanyuki, Kenya for Exercise
Askari Storm. The cases were identified while undergoing 6 days isolation upon arrival. 320 military
personnel have been placed under isolation rules with half being quarantine in tents. More than 1,000
troops were being fed on rations as orders were issued for cookhouse to close and local staff not to
report to work until the outbreak is under control.
15 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
vii. WHO Guidance & Other Protocols
No update was published by the WHO on 7 February 2021.
viii. CDC Guidance & Protocols
US CDC
The following updates were published by the US CDC on 7 February 2021.
Large Gatherings
Available at: https://www.cdc.gov/coronavirus/2019-ncov/your-health/large-gatherings.html
Small Gatherings
Available at: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/holidays/small-
gatherings.html
EU CDC
No update was published by the EU CDC on 7 February 2021.
ix. Vaccines/Therapeutics Development
Noteworthy reports are included to inform main developments of COVID-19 pharmaceutics. Past updates
are available from situation report 211 onwards. A global map and registry of trials is also visualised &
accessible at: https://www.covid-nma.com/dataviz/ and trial results are available at: https://covid-
nma.com/living_data/index.php. A living systematic review of vaccine trials is also accessable at
https://covid-nma.com/vaccines/ or https://covid-nma.com/ .
Vaccines
[1] Indonesia- Indonesia has approved the use of Sinovac Biotech vaccine for elderly.
[2] Iran- A second locally manufacture vaccine, Razi COV-Pars, made by Razi Vaccine and Serum Research
Institute will begin its human trials in Iran with about 130 volunteers for its first phase.
Therapeutics
No new updates were reported on 8 February 2021.
16 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Vaccine Approval Status
Table 6: Number of approving countries per vaccine
Vaccine Number of countries approving
FBRI EpiVacCorona 1
BioNTech/Pfizer BNT162b2 55
Moderna mRNA-1273 37
CanSino Ad5-nCoV 1
Gamaleya Sputnik V 16
Oxford/AstraZeneca AZD1222 43
Serum Institute of India Covishield 8
Bharat Biotech Covaxin 1
Sinopharm BBIBP-CorV 11
Sinopharm Inactivated 2
Sinovac CoronaVac 5
Source: https://covid19.trackvaccines.org/vaccines/
Adverse Reactions & Effects
The following table documents adverse reactions reported from approved vaccines and therapeutics.
New updates are bolded.
Table 7: Compilation of reports & guidance on adverse reactions
Vaccine Report/Guidance Reference
[Canada; Report] One person in Manitoba reportedly had an adverse
reaction after receiving the first dose on December 23. There were 490 [1]
more individuals vaccinated.
[United Kingdom; Report] Two British healthcare workers suffered
[2]
anaphylactic shock after receiving the vaccine.
[United States; Report] A healthcare worker in New York City suffered
anaphylaxis after receiving Pfizer BioNTech’s vaccine. The worker is
[3]
currently in a stable condition. 30,000 people have been vaccinated so
Pfizer BioNTech far.
[United States; Report] Two healthcare workers in northern Idaho and
the Treasure Valley, experienced severe allergic reactions after receiving
[4]
the vaccine. As of the time of reporting, one has fully recovered while
the other is expected to be discharged soon.
[United States; Report] There have been two cases of severe allergic
reaction in Alaska after receiving the COVID-19 vaccine. Symptoms of
[5]
the latest case include tongue swelling, hoarse voice and difficulty
breathing, which kicked in about 10 mins after receving the vaccine.
17 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
[United States; Report] An individual at Decatur Morgan hospital,
Alabama, experienced severe allergic reaction several minutes after [6]
getting the vaccine. The patient is currently in a stable condition.
[United States; Report] Two healthcare workers from Essentia Health,
Minnesota had non-severe allergic reactions to the vaccine. About 2,500
[7]
doses of the vaccines have been administered to frontline workers at
Essentia Health.
[United States; Report] According to Pfizer’s data submitted to the FDA,
the most common side effects were swelling and redness at the vaccine
injection site. Other noted common side effects in the trial included [8]
fatigue, headache and muscle pain, which had a greater chance of
occurring after the second dose than the first dose.
[United States; Guidance] The Centers for Disease Control and
Prevention (CDC) has issued new guidance on 21 December regarding
allergies and coronavirus vaccines after reports of severe allergic
[9]
reactions to the jab. In the new guidance, the CDC recommends that
those who have a severe reaction to the first shot of the vaccine should
not receive the second jab.
[United States; Guidance] Health experts have said that the side effects
of COVID-19 vaccines by Pfizer BioNTech (and Moderna) are short-term
and manageable. The American College of Allergy, Asthma &
Immunology recently released a guideline on the risk of allergic [10]
reactions to Pfizer BioNTech’s vaccine. The guideline is available at
https://acaai.org/news/american-college-allergy-asthma-and-
immunology-updates-guidance-risk-allergic-reactions-mrna.
[Canada; Report] Of 11,930 doses of Pfizer BioNTech’s vaccine
administered in British Columbia so far there have been 2 cases of [11]
allergic reaction.
[Israel; Report] On December 28, a 46-year-old man in Jerusalem
suffered severe anaphylactic shock one hour after receiving a COVID-19
vaccination. He is the first in Israel to have such a reaction, and is
reportedly allergic to penicillin. His condition has since stabilized.
[12]
Separately, a 75-year old man died of heart failure at home some hours
after receiving Pfizer BioNTech’s vaccine. The man was reported to have
heart disease and cancer, and had suffered a number of previous heart
attacks. While investigations are still ongoing, preliminary findings
indicated that the death did not appear to be connected to the shot.
[Finland; Report] On January 2, the first adverse reaction against the
[13]
vaccine was reported. No further details were released.
[Mexico; Report] A 32-year-old doctor in Mexico has been admitted to
intensive care unit with seizures, breathing difficulties and possible
encephalomyelitis. While the cause of the adverse reaction is still under
investigation, preliminary diagnosis indicates encephalomyelitis. The
patient condition has been stablized and is receiving treatment to
[14]
reduce inflammation.
[15]
[Update] The doctor was allergic to sulfa drugs and has a family history
of allergies. After developing allergic reaction, medication was
administered to recover from the symptoms. However, she had
subsequently suffered from convulsion. Diagnosis at that time was
18 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
allergic reaction to the vaccine but the cause for convulsion and
reduction of muscle strength is still being studied.
[Bulgaria; Report] As of January 4, Bulgaria’s Medicines Agency had
received four reports of adverse reactions. One case of dizziness after
administration, two cases of local pain at the vaccinated site, and one [16]
case of a slight temperature increase. These side effects had passed off
in less than a day.
[Portugal; Report] A portugese health worker had suffered a sudden
death 2 days after being vaccinated on 30 Dec. She did not suffer from
any adverse side-effect after vaccinated and did not has any health
problem. An autopsy is expected to be conducted soon.
[17]
[18]
[Update] In a 5 January 2020 press release, the Portuguese Ministry of
Justice informed that preliminary data from the autopsy showed “no
evidence of a causal relationship between the death and the vaccine
that was received.”
[Mexico; Report] By January 5, more than 44,000 people have received
the first shot. As of January 4, about 110 people had reported allergic
reaction to the vaccine but 80% were mild and only 5 people require
hospitalization. Only one person was severely affected and remain in
hospital.
[Update] As of 16 January 2021, 753 adverse events (729 mild and 24 [19]
serious) allegedly caused by vaccination and immunization were [20]
reported since 24 December 2020. The 24 serious events were reported
from Coahuila (7 reports), Mexico City (4 cases), Chihuahua, State of
Mexico, Guanajuato, Oaxaca and Yucatan (2 reports each) and Baja
California, Hidalgo and Jalisco (1 report each). Of the 24 serious events
reports, 6 remain hospitalized while the remaining have been
discharged.
[United States; Publication] Centre of Disease Control and Prevention
(CDC) has reviewed on the allergric reaction to the first dose of vaccine
during 14 to 23 December. Among the 1,893,360 first doses
administered, 4,393 (0.2%) adverse events were reported. 21 cases of
anaphylaxis (11.1 cases per million doses) were detected and 17 of them
had history of allergies or allergy reaction. Of the 21 cases, 4 of them
were hospitalized including 3 in intensive care and 20 of them had
discharged or recovered by 23 December. There were no death [21]
reported. [22]
[23]
[Update] The total number of cases of anaphylaxis has been updated to
29 as on 6 January.
[Update] CDC has roughly estimated that one in a hundred thousand
people who received the Pfizer vaccine had severe allergic reactions. An
average rate of 11.1 anaphylaxis cases per one million doses
administered was estimated.
[United States; Report] A Florida doctor had died several weeks after
receiving the vaccine on 18 Dec. He had suffered from hemorrhagic [24]
stroke due to a lack of platelets. It is unclear if his death was related to [25]
the vaccine while his death is being investigated. It was reported that he
19 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
had dots on the skin indicating internal bleeding 3 days after the
injection. Pfizer and BioNTech had not received any prior indication of
possible connection to thrombocytopenia.
[Update] As of 12 Jan, no evidence was obtained to suggest a
connection between the vaccine and the death.
[Canada; Report] Nine reports of adverse medical reactions which
include a total of 65 symptoms, eight of which were considered severe,
have been reported as of Jan. 1 but none were considered to be
unexpected side effects.
[Update] Fifteen new reports of adverse medical reactions, five of which
were considered severe, have been reported as between January 1 and
January 8. As of January 8, 24 reports of adverse effects were reported,
[26]
consisting of 10 serious and 14-nonserious reports. All reports were
[27]
considered to be expected side effects.
[28]
[Update] Sixty-six new reports of adverse medical reactions, 17 of which
were considered severe, have been reported as between January 9 and
January 15. As of January 15, 90 reports of adverse effects were
reported, consisting of 27 serious and 63-nonserious reports. Most
frequently reported adverse events were vaccination site reactions,
paraesthesia, pruritis, urticaria, headache, hypoaesthesia, nausea and
anaphylaxis.
[France; Report] Six reports of serious adverse effects with a favourable
outcome were reported in France during the 3rd week of vaccination: 4
[29]
cases of allergic reactions and 2 cases of tachycardia. Around 30 cases
of non-serious adverse effects have been reported since 12 Jan 2021
[Norway; Report] As of 14 Jan 2021, 29 reports of side effects were
reported in Norway. The 29 reports consisted of 13 deaths, 9 serious
side effects and 7 less serious side effects. The deaths were all amongst
frail and elderly patients in nursing homes, aged at least 80 years. [30]
Serious side effects reported included allergic reactions, strong malaise
and severe fever. Less serious side effects include severe pain at
injection site.
[United States; Report] A healthcare worker in Alaksa experienced an
allergic reaction to the Moderna COVID-19 vaccine, 10 minutes within
[31]
receiving it on January 12. There was no information on allergy history
of the healthcare worker.
[Israel, Report] At least 13 cases of mild facial paralysis have been
[32]
reported upon receiving the vaccine.
[United Kingdom, Report] A severe adverse medical reaction was
reported from a medical councillor aged 42 years within minutes after
receiving his vaccine on 8 January 2021. The councilor experienced [33]
breathing difficulties, fever and muscle aches, and was hospitalized for 1
day before his condition stabilized and eventually recovered.
[Ireland, Report] As of 11 January 2021, 81 adverse events from
[34]
vaccination were reported, all involving expected mild side effects.
[Singapore, Report] As of 27 January 2021, a total of 432 AEFIs were
[35]
reported amongst the 113,000 people who received the vaccine. All
[36]
reports were mild and reported expected side effects arising from
20 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
vaccination, except for 3 cases of anaphylaxis (SAE) reported. The cases
were in their 20s and 30s, had a history of allergies, but no history of
anaphylaxis which would have precluded them from receiving the
vaccine. All 3 cases have recovered and were discharged from the
hospital after a day’s observation or treatment.
[Update] As of February 1, 2021 all four cases of anaphylaxis following
vaccination have recovered, with none requiring intensive care unit
support.
[Belgium, Report] As of January 26, 2021 a total of 262 AEFIs were
reported out of 243,412 vaccines administered, of which 37 were
[37]
serious AEFIs. Of the serious AEFIs reported, 14 were deaths amongst
those aged over 70 years (9 deaths) or 90 years (5 years).
[Croatia, Report] As of February 1, 2021 a total of 430 AEFIs were
reported, of which 26 were allergic reactions and the rest were mild side
[38]
effects. The allergic reactions included 2 serious reactions, and 24 milder
reactions.
[United Kingdom; Report] A study conducted by Zoe, a British health
science company had found that 37% of about 40,000 vaccinees in UK
who were mostly healthcare workers had reported local side effects
(e.g. swelling or pain near injection site) after first dose and 45% after [39]
second dose. Systemic side effects (e.g. fatigue) were rare with 14%
after first dose and 22% after second dose. The side effect reported
were lower as compared to FDA trials.
[Romania; Report] A doctor from Valcea county had experienced
temporary facial paralysis after receiving the second dose and has since
fully recovered. This is the first rare and major side effect reported in
[40]
Romania. Since 27 Dec, there has been more than 2,100 common and
minor side effects reported with a total of 629,279 people vaccinated by
4 Feb.
[United Kingdom; Report] The Medicines and Healthcare products
Regulatory Agency (MHRA) had reported on the side effects of 7 million
vaccine doses (5.4 million Pfizer/BioNTech & 1.5 million of the
AstraZeneca) administered by 24 Jan. Yellow card system was used for
vaccinated people to report side effect. There was an average of 3
yellow cards per 1,000 doses administered. There were 16,756 yellow
[41]
card for the Pfizer-BioNTech vaccine; 6,014 for the Oxford University-
AstraZeneca vaccine and 50 for unspecified brand of the vaccine. Most
reports were related to injection site or otherwise generalized
symptoms (e.g. flu-like illness). These symptoms had occured shortly
after vaccination and were not associated with more serious or lasting
illness.
[United States; Report] The FDA advisory committee has noted a special
side effect of the vaccine from the clinical trials involving several
patients with cosmetic facial fillers. The patients who experienced side
[42]
effect all had swelling and inflammation in the area that was given the
Moderna filler. All reactions were resolved following treatment with steroids and
antihistamines.
[United States; Report] A Boston doctor experienced severe allergic
reactions after receiving the Moderna COVID-19 vaccine on December [43]
24. The doctor has a history of shellfish allergy.
21 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
[Canada; Report] On December 17, the US FDA reported two cases of
adverse reactions in individuals who had received the Moderna vaccine.
Both patients previously had dermal fillers and experienced some [44]
swelling following the vaccination. The cases were likely to have
occurred in Toronto, Canada.
[United States; Report] A frontline worker in Robstown had experienced
immediate numbness on the face after receiving the vaccine a week ago [45]
but continues to have soreness and redness to her arms.
[United States; Publication] Phase 3 clinical trial involving 30,420
volunteers had observed higher frequency of moderate, transient
reactogenicity after vaccination in the vaccine group. Serious adverse
events were rare and the incidence was similar between the placebo
and vaccine groups. Hence there were no safety concern, apart from the
[46]
transient local and systemic reactions.
[47]
[Update] The vaccine showed a 94.1% efficacy rate in its phase 3 trial,
and serious adverse events occurred in just 0.6% of patients. A total of 2
deaths were reported in the vaccine group, one was due to
cardiopulmonary arrest and the other was a suicide.
[United States; Report] On 31 December, the Oregon Health Authority
reported a case of anaphylaxis after a healthcare worker had taken the [48]
vaccine this week and is recovering in the hospital.
[Guidance] A new guidance from the American Society for Dermatologic
Surgery (ASDS) has been released regarding side effects from the SARS-
CoV-2 mRNA vaccine on dermal fillers. FDA data reports show three
[49]
participants out of 15,184 who received at least one dose of Moderna’s
mRNA-1273 vaccine have developed lip for facial swelling in areas of
dermal filler placement.
[United States; Report] A Missouri healthcare worker experienced
severe allergic reaction after receiving the Moderna COVID-19 vaccine
[50]
on December 29. The healthcare worker has a history of severe allergy
reaction to MRI contrast dye.
[United States, Report] Six reports of allergy reactions requiring medical
attention 24 hours from vaccination, were reported amongst healthcare
workers on 14 January 2021. The healthcare workers were vaccinated
with lot 41L20A from the same vaccination site in San Diego. The site is [51]
temporarily closed for now and using other vaccines. California health
officials recommend suspending the use of lot 41L20A, until
investigation are complete.
[United States, Report] A fatality was reported in a resident from a
retirement home, after receiving the vaccine. Investigation on whether [52]
the fatality was linked to receiving the vaccine is underway.
[United States, Report] As of January 29, 2021 a total of 287 AEFIs were
reported amongst 250,000 vaccines administered in Texas, of which 11
were serious AEFIs. The 11 AEFI reports included the death of an 84
years-old woman, permanent disability in another patient, and the [53]
remaining spent at most 4 days hospitalized. [54]
[Update] As of 5 Feb, 2021, the The Centers for Disease Control had
reported that 619,452 second doses have been administered in Texas
22 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
with 15 significant reports of side effect. Only 4 of them required
hospital stay that had lasted less than 5 days.
[Croatia, Report] As of February 1, 2021 a total of 13 AEFIs were
[55]
reported, all of which were mild side effects.
[Argentina; Report] Of the total 32,013 patients who had received the
Sputnik V vaccine, 1% (317 patients) had reported mild adverse reaction (fever [56]
and headache).
[India, Report] Ninety-three reports of adverse events following
immunization with Astrazeneca & Oxford Uni. ( and Bharat Biotech)
vaccines were reported from Delhi (51 mild and 1 serious report),
Haryana (13 mild reports), Maharashtra (14 mild reports) and Kolkata
(13 mild and 1 serious report). No fatalities have been reported.
[Update] Between 16 January and 17 January, 447 reports of adverse
events following immunization have been reported across India. Only 3
of the reports involved serious adverse events requiring hospitalization,
of which only 1 remains hospitalized.
[Update] 82 AEFIs were reported across India on 20 January 2021. All
AEFIs reported were mild cases.
[Update] On the 22 Jan, Day 4 of the coronavirus vaccination drive in
Delhi, 5,942 people were reportedly administered the shots and adverse
events following immunisation (AEFI) was reported in 24 persons. [57]
[58]
[Update] On 24 Jan, the fifth day of India’s Covid-19 vaccination drive, [59]
the city of Gurugram reported 3 cases of AEFI amongst 3,055 shots [60]
Astrazeneca & administed. [61]
Oxford Uni. [62]
[Update] The Union Ministry of Health and Family Welfare in India [63]
announced 23 January that over 10 lakh people had already been [64]
immunised in the first six days (up to 21 January), but the total number [65]
of AEFIs reported by the ministry in its daily press releases so far adds up [66]
to 1,239 out of 15,37,190 inoculations, or 0.08 per cent. Just 11 people
have had to be hospitalised (0.0007 per cent), while seven deaths have
been reported — six of which are “not causally linked” to the vaccine,
while in the seventh case, the post mortem report is awaited.
[Update] A total of 19,50,183 beneficiaries were inoculated in 35,785
sessions till 7.10 pm on Monday 25 Jan, including 3,34,679 in 7,171
sessions during the day, the ministry said. A total of 348 adverse events
following immunisation (AEFIs) were reported till 7.10 pm on 25 Jan, the
10th day of the vaccination drive.
[Update] A total of 213 ARFIs were reported up till 7 pm on January 29,
2021 across India, of the 33,68,734 vaccines administered
[Update] The Minstry of Health and Family Welfare had reported more
than 40 lakh healthcare and frontline workers have been vaccinated. A
total of 8,563 AEFIs (0.18%) and 34 hospitalized cases (0.0007%) have
23 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
been reported. There were 19 deaths of vaccinated people but there has
been no evidence on the link between vaccination and the death.
[India, Report] A female volunteer from a village in Andhra Pradesh
had died 2 days after administered with the vaccine on 5 Feb. She was
Unspecified normal and there was no symptoms of fever or adverse effect after the [67]
vaccination. Post-mortem will be conducted to identify the cause of
death.
Therapeutic/Drug Report/Guidance Reference
NIL NIL NIL
x. Scientific Publications with Epidemiology and Clinical Focus
Clinical Stratification of Pregnant COVID-19 Patients based on Severity: A Single Academic Center
Experience [1]
Objective: The aim of this study was to describe baseline characteristics of a cohort of pregnant women
infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and determine if these
correlate with disease severity and perinatal outcomes.
Study design: This was a retrospective cohort trial conducted at the University of Texas Medical Branch
Galveston, Texas. All pregnant women presented to our medical center, who were screened and tested
positive for SARS-CoV-2 virus, were included. We stratified our study population in three groups:
asymptomatic, symptomatic not requiring oxygen therapy, and patients requiring oxygen support to
maintain oxygen saturation >94%. Relevant population characteristics, laboratory data, and maternal and
neonatal outcomes were abstracted. A p-valueFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
xi. Sources
Global Risk Assessment
1. https://www.trip.com/travel-restrictions-covid-19/
2. https://losangeleno.com/coronavirus-los-angeles/october-1/
3. https://www.europeanpharmaceuticalreview.com/news/126922/study-shows-anticoagulation-
therapy-beneficial-for-covid-19-patients/
4. https://www.nytimes.com/2020/09/02/health/coronavirus-steroids.html
5. https://news.abs-cbn.com/overseas/04/22/20/israeli-firm-treating-covid-19-patients-with-placenta-
cells-reports
6. https://www.khaleejtimes.com/coronavirus-pandemic/uae-stem-cell-therapy-for-coronavirus-
treats-over-2000-patients-1200-fully-recover-
7. https://www.dailytarheel.com/article/2020/11/university-baric-lab-researchers
8. https://www.todayonline.com/world/relief-neurorx-say-emergency-treatment-rlf-100-helps-
critically-ill-covid-patients
9. https://www.channelnewsasia.com/news/world/us-plasma-treatment-covid-19-donald-trump-fda-
13046312
10. https://www.reuters.com/article/us-health-coronavirus-eli-lilly-fda-idUSKBN27P35L
11. https://bc.ctvnews.ca/vancouver-developed-covid-19-treatment-approved-for-use-1.5201168
12. https://www.outsourcing-pharma.com/Article/2020/11/23/FDA-grants-EUA-for-combo-COVID-19-
treatment
13. https://tribune.com.pk/story/2246746/3-ethiopia-use-dexamethasone-covid-19-patients/
14. http://www.xinhuanet.com/english/2020-12/03/c_139560671.htm
Travel Bans/Advisories & Quarantine Orders
1. https://www.thelocal.at/20210207/austria-tightens-border-controls
2. https://news.gtp.gr/2021/02/07/greece-extends-covid-19-travel-restrictions-domestic-international-
flights/
Lockdowns
Refer to Situation Report 91 for all updates before 1st May 2020
1. https://cyprus-mail.com/2021/02/07/coronavirus-cyprus-enters-second-phase-of-measures-
relaxations-on-monday/
2. https://news.gtp.gr/2021/02/07/greece-extends-covid-19-travel-restrictions-domestic-international-
flights/
3. https://www.channelnewsasia.com/news/asia/covid-19-malaysia-chinese-new-year-reunion-dinner-
prayers-14132416
4. https://saudigazette.com.sa/article/603300
Military Surveillance
1. https://www.mirror.co.uk/news/uk-news/british-troops-lockdown-kenya-after-23459521
Vaccine/Therapeutics Development
1. https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/07/indonesia-approves-china039s-
sinovac-vaccine-for-the-elderly
2. https://www.aljazeera.com/news/2021/2/7/iran-to-start-human-trials-on-second-local-covid-vaccine
25 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
Compilation of Adverse Reactions
1. https://www.cbc.ca/news/canada/manitoba/covid-19-vaccine-manitoba-adverse-affect-1.5854915
2. https://www.dailymail.co.uk/news/article-9085941/Pfizer-COVID-19-vaccine-causing-allergic-
reactions-rate-superior-shots.html
3. https://www.wsj.com/articles/new-york-city-health-care-worker-has-severe-adverse-reaction-to-
covid-19-vaccine-11608760982
4. https://www.eastidahonews.com/2020/12/two-have-severe-allergic-reactions-after-receiving-covid-
19-vaccine-in-idaho/
5. https://www.thehindu.com/news/international/second-severe-reaction-to-covid-19-vaccine-
reported-in-us/article33370132.ece
6. https://www.wvtm13.com/article/severe-allergic-reaction-reported-following-covid-19-immunization-
in-alabama/35059745#
7. https://www.fox21online.com/2020/12/21/two-essentia-health-employees-had-allergic-reactions-to-
covid-19-vaccine/
8. https://www.capegazette.com/article/covid-19-vaccine-discussing-most-common-side-effects/213242
9. https://www.independent.co.uk/news/world/americas/covid-vaccine-pfizer-allergic-reaction-cdc-
b1776776.html
10. http://www.koreabiomed.com/news/articleView.html?idxno=10027
11. https://bc.ctvnews.ca/not-unexpected-b-c-reports-2-allergic-reactions-to-covid-19-vaccine-1.5247974
12. https://www.timesofisrael.com/family-ministry-say-no-link-to-vaccine-as-man-dies-hours-after-
inoculation/
13. https://www.aninews.in/news/world/europe/finland-confirms-first-adverse-reaction-to-
pfizerbiontech-covid-19-vaccine20210102190911/
14. https://www.livemint.com/news/world/arg-reports-adverse-reaction-to-sputnik-v-doc-gets-side-
effects-from-pfizer-jab-11609633103810.html
15. https://mexiconewsdaily.com/news/coronavirus/covid-vaccinations-have-produced-110-allergic-
reactions/
16. https://sofiaglobe.com/2021/01/04/second-shipment-of-covid-19-vaccines-arrives-in-bulgaria/
17. https://www.dailymail.co.uk/news/article-9111311/Portuguese-health-worker-41-dies-two-days-
getting-Pfizer-covid-vaccine.html
18. https://healthfeedback.org/claimreview/covid-19-vaccine-did-not-cause-the-death-of-a-portuguese-
woman-contrary-to-social-media-posts-suggestions/
19. https://mexiconewsdaily.com/news/coronavirus/covid-vaccinations-have-produced-110-allergic-
reactions/
20. https://www.explica.co/six-people-are-hospitalized-for-adverse-reactions-to-vaccine/
21. https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm?s_cid=mm7002e1_w
22. https://www.thehealthsite.com/news/29-cases-of-anaphylaxis-reported-after-initial-mrna-based-
covid-19-shots-in-the-us-789791/
23. https://clicklancashire.com/2021/01/09/severe-allergic-reaction-in-21-vaccinated-people.html
24. https://www.usatoday.com/story/news/health/2021/01/06/death-florida-doctor-following-pfizer-
covid-19-vaccine-under-investigation-gregory-michael/6574414002/
25. https://lancasteronline.com/news/health/news-briefs/article_2ec8e295-3dd6-5e6f-a719-
b1e456e67e3e.html
26. https://www.cbc.ca/news/politics/adverse-events-covid-19-vaccines-1.5866357
27. https://health-infobase.canada.ca/covid-19/vaccine-safety/#summary
26 | P a g e Centre for infectious disease epidemiology and researchFor citation: Centre for Infectious Disease Epidemiology and Research-NUS.
COVID-19 Situation Report 375. 8 February 2021
28. https://health-infobase.canada.ca/covid-19/vaccine-safety/#a3
29. https://ansm.sante.fr/S-informer/Actualite/Point-de-situation-sur-la-surveillance-des-vaccins-contre-
la-COVID-192
30. https://sputniknews.com/europe/202101151081772909-norway-links-13-deaths-to-pfizer-vaccines-
side-effects/
31. https://abc7.com/covid-19-pandemic-vaccine-moderna-side-effects/9012113/
32. https://www.rt.com/news/512736-israel-facial-paralysis-13-covid-vaccine/
33. https://www.lep.co.uk/health/coronavirus/preston-councillor-rushed-hospital-severe-covid-vaccine-
side-effects-3103026
34. https://www.thejournal.ie/vaccines-lorraine-nolan-5328674-Jan2021/
35. https://www.channelnewsasia.com/news/singapore/anaphylaxis-covid-19-vaccine-severe-allergic-
reaction-moh-14063090
36. https://www.straitstimes.com/singapore/four-who-had-severe-allergic-reactions-from-covid-19-
vaccines-have-recovered-none-needed
37. https://www.socialnews.xyz/2021/01/30/belgium-reports-covid-19-surge-in-children/
38. https://www.total-croatia-news.com/news/50221-ventilators-in-croatia
39. https://www.forbes.com/sites/carlieporterfield/2021/02/04/more-than-one-in-three-people-in-uk-
study-report-side-effects-from-pfizer-coronavirus-vaccine/?sh=7ca46cb539ef
40. https://www.romania-insider.com/rare-side-effect-covid-vaccine-romania
41. https://newseu.cgtn.com/news/2021-02-06/UK-health-regulator-issues-report-on-side-effects-of-
COVID-19-vaccines-XDVbVoKdZm/index.html
42. https://health.economictimes.indiatimes.com/news/industry/us-healthcare-worker-suffers-allergic-
reaction-to-pfizer-vax/79789164
43. https://edition.cnn.com/2020/12/25/health/boston-health-care-worker-allergic-reaction-moderna-
coronavirus-vaccine/index.html
44. https://www.ctvnews.ca/health/coronavirus/2-patients-with-facial-fillers-saw-swelling-after-
receiving-moderna-vaccine-fda-1.5248564
45. https://www.kiiitv.com/article/news/health/coronavirus/vaccine/adverse-reactions-from-the-
coronavirus-vaccine-are-minor-health-experts-explain-the-reaction-a-woman-had-at-the-drive-thru-
clinic-in-robstown/503-cd33e1b5-138c-40e7-8e73-eef1f968e8cb
46. https://www.nejm.org/doi/full/10.1056/NEJMoa2035389
47. https://www.contagionlive.com/view/moderna-vaccine-study-data-shows-94-1-efficacy-serious-side-
effects-rare
48. https://katu.com/news/coronavirus/oregon-health-care-worker-hospitalized-after-severe-reaction-to-
coronavirus-vaccine
49. https://www.dermatologytimes.com/view/guidance-issued-for-covid-19-vaccine-side-effects-in-
dermal-filler-patients
50. https://fox4kc.com/tracking-coronavirus/important-information-to-know-after-metro-healthcare-
worker-suffers-severe-allergic-reaction-from-covid-19-vaccine/
51. https://www.marketwatch.com/story/california-health-official-urges-halt-to-300-000-moderna-
vaccinations-after-reports-of-allergic-reactions-01611011648
52. https://www.iheartradio.ca/am800/news/local-retirement-home-resident-dies-after-receiving-covid-
19-vaccine-investigation-launched-1.14400880
27 | P a g e Centre for infectious disease epidemiology and researchYou can also read
